Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Apply
Pegunigalsidase Alfa
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step